A randomized controlled trial of a multicomponent online stress reduction intervention in inflammatory bowel disease.
Farhad PeeraniMakayla WattKathleen P IsmondReid WhitlockLindsy AmbrosioNaomi HotteNicholas MitchellRobert J BaileyKaren KroekerLevinus A DielemanJesse SiffledeenAllen LimKaren WongBrendan P HalloranDaniel C BaumgartLorian TaylorMaitreyi RamanKaren L MadsenPuneeta TandonPublished in: Therapeutic advances in gastroenterology (2022)
People with inflammatory bowel disease (IBD) have high levels of stress, anxiety, and depression. Although IBD patients have expressed the need for online mental wellness interventions, the existing data to support these interventions in IBD are limited. In this trial, 101 IBD patients had the chance to participate in a 12-week online stress reduction intervention. In those patients randomly selected to participate in the online intervention, each week they received the following: a 20- to 30-min yoga, breathwork, and meditation video that they were asked to do 2-3 times a week, a 10- to 20-min mental wellness activity they were asked to do once during the week, and a 10-min telephone check-in with a study team member. Participants who were not selected to use the online intervention received a weekly motivational message by email. In all, 90 of the 101 participants (89%) completed the study with the mean age of participants being 43 years and the majority being females (75%). Ninety-one percent of participants who completed the intervention met the program target of doing the yoga, breathwork, and meditation video at least 2 times per week. Significant improvements were seen in perceived stress (by 22.4%), depression (by 29.5%), anxiety (by 23.7%), resilience (by 10.6%), and quality of life (by 8.9%). No changes were seen in IBD severity or in blood markers of inflammation. In conclusion, this study demonstrates evidence that a 12-week online stress reduction intervention had low dropout rates, high adherence and beneficial effects on stress, mental health, and quality of life measures. Continued feedback will be sought from study participants and our IBD patient partners to refine the intervention and assess the impact in future studies of patients with active IBD, as well as the impact of a longer/more intense intervention.
Keyphrases
- randomized controlled trial
- mental health
- end stage renal disease
- social media
- ejection fraction
- newly diagnosed
- chronic kidney disease
- health information
- peritoneal dialysis
- clinical trial
- type diabetes
- depressive symptoms
- healthcare
- ulcerative colitis
- climate change
- sleep quality
- adipose tissue
- metabolic syndrome
- case report
- palliative care
- tyrosine kinase
- weight loss
- mental illness